
2019 TAAIS Annual Meeting
The TAAIS Annual Meeting, spanning three half-days, will offer state-of-the-art advances in allergic, asthmatic and immunologic diseases. Nationally renowned experts from across the U.S. will engage the practicing allergist/immunologist and discuss the most challenging problems in patients with allergies, asthma and immunodeficiency. In addition, Allergy fellows-in-training will provide a first-hand snapshot of the exciting allergy/immunology research going on in the State of Texas.
Registration Fees
Member Type | Fee |
---|---|
TAAIS Member (Physician) | $250 |
TAAIS Member (Emeritus) | $250 |
TAAIS Member (NP/ PA-C) | $250 |
Non-TAAIS Member (Physician) | $475 |
Non-TAAIS Member (PhD or PharmD) | $475 |
Non-TAAIS Member (Other) | $475 |
Non-TAAIS Member (NP/PA-C) | $300 |
Fellow-in-Training | FREE |
Speaker | FREE |
Target Audience
- A/I physicians
- NPs, PAs and nursing staff working with A/I practices
- PhDs, PharmDs and others involved with A/I patients or research
- Fellows-in-Training
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the therapeutic potential of biologics affecting key immunopathogenic pathways in asthma
- Explain the pathophysiology of atopic dermatitis
- Discuss the therapeutic potential of biologics for the mangement of antihistamine-resistant chronic urticaria
- Develop a framework for how biologics work and when to use them in treating stopic dermatitis
- Identify an academic allergy/immunology model for physician leadership in patient care, reserach, and education
- Describe treatment approaches for reducing asthma exacerbations in children with asthma
- Explain the basics of employment law and what is legally required to run and protect a business
- Discuss advantages and limitations of component resolved testing in food allergy
- Formulate and categorize the muliple causes of provider burnout and stress
- Compare and contrast potential solutions to provider stress and burnout, specifically with regard to allergy and immunology providers
- Explain the latest update to the drug allergy practice parameter
Date | Start Time | End Time | Presentation Topic | Faculty |
4/5/2019 | 7:15am | 8:00am | Breakfast & Registration | |
8:00am | 9:00am | Biologics in Asthma | Thomas B. Casale, MD | |
9:00am | 10:00am | Atopic Dermatitis Update | John C. Browning, MD | |
10:00am | 10:30am | Break with the Exhibitors | ||
10:30am | 11:30am | Andrew Grant Honorary Lecture: Biologics for Chronic Urticaria | Thomas B. Casale, MD | |
11:30am | 12:30pm | Biologics for Atopic Dermatitis | John C. Browning, MD | |
12:30pm | Adjourn | |||
4/6/2019 | 7:15am | 8:00am | Breakfast | |
8:00am | 9:00am | William T. Shearer, MD, PhD Memorial Lecture: William T. Shearer, MD, PhD: Meeting the Academic Challenge with 40 Years of Service to Texas | I. Celine Hanson, MD | |
9:00am | 9:15am | Examining Predictors of Epinephrine Use in Positive Oral Food Challenges | Mariam Guenther, MD | |
9:15am | 9:30am | Characteristics of Venom Allergy at Initial Evaluation: Is Fire Ant Hypersensitivity Similar to Flying Hymenoptera? | Sofia Szari, MD | |
9:30am | 9:45am | Quality of Life Evaluation of Food Allergies: A Tertiary Care Perspective | Jennifer Miller, MD | |
9:45am | 10:00am | Elevated Serum Fortilin Levels in Subjects with Chronic Idiopathic Urticaria | Albert Y. Wu, MD | |
10:00am | 10:30am | Break with the Exhibitors | ||
10:30am | 11:30am | Update on Pediatric Asthma | Leonard B. Bacharier, MD | |
11:30am | 12:30pm | HR Legal Issues: The Nuts & Bolts of Employment Law to Run a Successful Business | Penelope Phillips, JD | |
12:30pm | Adjourn | |||
4/7/2019 | 7:00am | 7:30am | Breakfast | |
7:30am | 8:30am | Food Allergy Component Testing & the New Guideline | Matthew Greenhawt, MD | |
8:30am | 9:30am | Allergy & Immunology Healthcare Provider Wellness (Ethics) | Anil Nanda, MD | |
9:30am | 10:00am | Break with the Exhibitors | ||
10:00am | 11:00am | Updated Drug Allergy Practice Parameter: What's New? | David A. Khan, MD | |
11:00am | Adjourn | |||
Planning Committee
J. Andrew Bird, MD FAAAAI
UT Southwestern Medical Center, Dallas, TX
Relevant relationships: DBV Technologies, Aimmune Therapeutics, Pfizer (advisory board); Aimmune Therapeutics, DBV Technologies, Medscape (speaker); Foresite Capital Consulting (consultant); Pharm Olam International (therapeutic trial)
David Khan, MD FAAAAI
UT Southwestern Medical Center, Dallas, TX
Relevant relationships: Aimmune (advisory board); Genentech (speaker)
William Lumry, MD FAAAAI
Allergy and Asthma Specialists, Dallas, TX
Relevant relationships: Adverum, BioCryst, CSL Behring, OptumRx, Pharming (consultant); Genentech, Octapharma, BioCryst, Green Cross, Menlo, NeRRE, Novartis, Sanofi, Teva/Watson, CSL Behring, Shire, Therapure (research grant); Genentech, Optinose, Sanofi-Regeneron, CSL Behring, Shire (speaker)
Connie Mawer
Executive Director, Texas Allergy, Asthma and Immunology Society, Austin, TX
Relevant relationships: None
Vivek Rao, MD
Advanced Allergy and Asthma Care, Odessa, TX
Relevant relationships: None
Faculty
Leonard Bacharier, MD FAAAAI
Washington University, St. Lous, MO
Relevant relationships: Boehringer Ingelheim, Circassia, GSK, Regeneron, Teva (advisory board); Merck, Vectura, DBV Technologies (Consultant); Sanofi, Novartis, AstraZeneca (speaker)
John Browning, MD
Texas Dermatology, San Antonio, TX
Relevant relationships: Pfizer (speaker, research grant), Regeneron (research grant)
Thomas Casale, MD FAAAAI
University of South Florida, Tampa, FL
Relevant relationships: Sanofi-Regeneron, Aimmune, Novartis, Genentech, Boehringer Ingelheim, AstraZeneca (advisory board); Novartis (DSMC chair)
Matthew Greenhawt, MD MBA MSc
Children's Hospital Colorado, Aurora, CO
Relevant relationships: Sanofi (advisory board)
Mariam Guenther, MD
UT Southwestern Medical Center, Dallas, TX
Relevant relationships: None
I. Celine Hanson, MD
Baylor College of Medicine, Spring, TX
Relevant relationships: Shire (speaker)
Jennifer Miller, MD
Baylor College of Medicine, Houston, TX
Relevant relationships: None
Anil Nanda, MD FAAAAI
Asthma and Allergy Center, Lewisville, TX
Relevant relationships: None
Penelope Phillips, Esq.
Felhaber Larson, Minneapolis, MN
Relevant relationships: None
Sofia Szari, MD
San Antonio Uniformed Services Health Education Consortium, Lackland AFB, TX
Relevant relationships: None
Albert Wu, MD
UT Medical Branch - Galveston, Galveston, TX
Relevant relationships: None
Content Reviewers
Sara Lowe, NP
Medical College of Wisconsin, Milwaukee, WI
Relevant relationships: None
Brian Schroer, MD
Cleveland Clinic Foundation, Cleveland, OH
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment: Name of employer and job title.
- Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and (name of non-accredited provider). The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on December 31, 2019. Requests to claim credit on or after January 1, 2020 will be subject to an administrative fee.
AAAAI Privacy Policy
Questions
Activity-related questions should be directed to Connie Mawer at [email protected].
Registration and credit claiming questions should be directed to [email protected].
Available Credit
- 11.00 AttendanceAttendance credit.
- 11.00 CECE credit.
- 11.00 CMECME credit.